GEMMs as Preclinical Models for Testing Pancreatic Cancer Therapies

DMM Disease Models and Mechanisms - United Kingdom
doi 10.1242/dmm.021055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Company of Biologists

Related search

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Precious GEMMs: Emergence of Faithful Models for Ovarian Cancer Research

Journal of Pathology
Forensic MedicinePathology
2018English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

Colon Cancer: Current Treatments and Preclinical Models for the Discovery and Development of New Therapies

2013English

HER3 as Biomarker and Therapeutic Target in Pancreatic Cancer: New Insights in Pertuzumab Therapy in Preclinical Models

Oncotarget
Oncology
2014English

MTOR Inhibitor-Based Combination Therapies for Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Targeted Therapies for Pancreatic Cancer and Hurdles Ahead

Anticancer Research
MedicineCancer ResearchOncology
2018English

Combination Testing of Cediranib (AZD2171) Against Childhood Cancer Models by the Pediatric Preclinical Testing Program

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy